Malignant Oral Cavity Neoplasm — Trials

Malignant Oral Cavity Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

379 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 111
Recruiting: 57
Ph III recruiting: 9
Growth YoY: +11.5%
Industry share: 6%
Top sponsor: National Cancer Institute (NCI)
Termination share: 31.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (45)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02295540	Hypofractionated Radiation Therapy Followed by Surgery in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity	withdrawn	N/A	0	Rutgers, The State University of New JerseyOTHER	1	Sep 28, 2022	clinicaltrials
NCT01718223	Photodynamic Therapy Using Temoporfin Before Surgery in Treating Patients With Recurrent Oral Cavity or Oropharyngeal Cancer	withdrawn	N/A	0	Roswell Park Cancer InstituteOTHER	0	Sep 3, 2014